AMAM · Categories · Form 4

AMAM - SEC Form 4 insider transactions

Ambrx Biopharma Inc. (AMAM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for AMAM

• 822d
  SEC Form 4 filed by Hermans Kate

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  SEC Form 4 filed by Loesberg Janet

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  O'Connor Daniel J. returned 48,202 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  SEC Form 4 filed by Glover Stephen C.

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  SEC Form 4 filed by Aromando Andrew

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  Nelson Sonja returned 22,936 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  SEC Form 4 filed by Dalesandro Margaret

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 822d
  SEC Form 4 filed by Maier Paul V

  4 - Ambrx Biopharma, Inc. (0001990550) (Issuer)
• 1005d
  SEC Form 4: Dalesandro Margaret was granted 195,833 units of Ordinary Shares

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1066d
  SEC Form 4 filed by O'Connor Daniel J.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1066d
  SEC Form 4 filed by Aromando Andrew

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1066d
  SEC Form 4 filed by Nelson Sonja

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1075d
  SEC Form 4 filed by Darwin Global Management, Ltd.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1094d
  SEC Form 4 filed by Glover Stephen C.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1094d
  SEC Form 4 filed by Chang Xiaowei

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1094d
  SEC Form 4 filed by Hermans Kate

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1094d
  SEC Form 4 filed by Maier Paul V

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1094d
  SEC Form 4 filed by Loesberg Janet

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1108d
  SEC Form 4 filed by Glover Stephen C.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1129d
  SEC Form 4 filed by Aromando Andrew

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1136d
  SEC Form 4 filed by Nelson Sonja

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1136d
  SEC Form 4 filed by O'Connor Daniel J.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1144d
  SEC Form 4 filed by Cormorant Asset Management, Lp

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1147d
  SEC Form 4 filed by Cormorant Asset Management, Lp

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1179d
  SEC Form 4: Cormorant Asset Management, Lp bought $10,211,400 worth of Ordinary Shares (1,000,000 units at $10.21)

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1188d
  SEC Form 4 filed by Darwin Global Management, Ltd.

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1223d
  SEC Form 4 filed by Rupalla Katrin

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1223d
  SEC Form 4 filed by Nelson Sonja

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1223d
  SEC Form 4 filed by Maier Paul V

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1223d
  SEC Form 4 filed by Loesberg Janet

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)
• 1223d
  SEC Form 4 filed by Hermans Kate

  4 - Ambrx Biopharma Inc. (0001836056) (Issuer)

Other AMAM categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends